Insmed To Present at Three March Conferences

Rhea-AI Summary

Insmed Incorporated (INSM) to present at multiple investor conferences in March 2024, aiming to engage with the investment community and showcase its commitment to patients with serious and rare diseases.

BRIDGEWATER, N.J., Feb. 29, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences:

• The TD Cowen 44^th Annual Health Care Conference in Boston on Monday, March 4, 2024, at 2:50 p.m. ET in a fireside chat
• The Leerink Partners Global Biopharma Conference 2024 in Miami on Tuesday, March 12, 2024, at 1:00 p.m. ET in a fireside chat
• The Barclays 26^th Annual Global Healthcare Conference in Miami on Wednesday, March 13, 2024, at 4:35 p.m. ET in a fireside chat

Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is also advancing an early-stage research engine encompassing a wide range of technologies and modalities, including artificial intelligence-driven protein engineering, gene therapy, and protein manufacturing. Insmed is headquartered in Bridgewater, New Jersey, with additional offices and research locations throughout the United States, Europe, and Japan. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-three-march-conferences-302075670.html

SOURCE Insmed Incorporated

FAQ

When will Insmed Incorporated (INSM) be presenting at the TD Cowen 44th Annual Health Care Conference?

Insmed will present at the TD Cowen 44th Annual Health Care Conference in Boston on Monday, March 4, 2024, at 2:50 p.m. ET.

Where can investors access the webcasts of Insmed's fireside chats at the investor conferences?

Investors can access the webcasts of Insmed's fireside chats at the investor conferences by visiting the investor relations section of the Company's website at www.insmed.com.

How long will the webcasts of Insmed's fireside chats be available for viewing after the live events?

The webcasts of Insmed's fireside chats will be archived for a period of 30 days following the conclusion of the live events.